Biocon informs about press release

28 Dec 2020 Evaluate
Biocon has informed that it has enclosed press release titled, ‘Biocon expands generic formulations portfolio with the launch of Tacrolimus capsules in the US’,

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

305.85 -0.05 (-0.02%)
17-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1530.00
Dr. Reddys Lab 5802.00
Cipla 1399.35
Zydus Lifesciences 1051.90
Lupin 1653.75
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.